⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 2026The Lancet

Winner of the 2025 Wakley–Wu Lien Teh Prize: beyond precision medicine

Esther Lau Helena Hui Wang Yuanyuan Wang Shangrong Han Jiefang Huang Pingyue Jin Haoyu Wang Peng Zhang Baoguo Jiang Richard Horton

View at Publisher

Ask AI

Bookmark

Share

Key Points

Highlights the evolution and impact of precision medicine on healthcare, emphasizing innovative approaches.
Identifies key biomarkers that enhance treatment outcomes, potentially transforming patient care over the next decade.
Explores molecular pathways involved in disease processes, making a case for personalized therapeutic strategies.
Calls for further exploration of integrating genomics into routine clinical practice to improve healthcare delivery.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

This award-winning analysis showcases advancements in precision medicine, highlighting future implications for genomics and therapeutics.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lau et al. (2026) studied this question.

synapsesocial.com/papers/69a75de7c6e9836116a2833f https://doi.org/10.1016/s0140-6736(26)00098-x

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trialThe Lancet · 2022
2Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet · 2026
3LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialThe Lancet · 2024
4Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trialThe Lancet · 2026
5Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trialThe Lancet · 2020
6Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trialThe Lancet · 2021
7Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trialThe Lancet · 2022
8Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet · 2002
9Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet · 2015
10Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trialThe Lancet · 2022

More from The Lancet

More from Planetary Science Institute

More from Peking University Shenzhen Hospital

More from Lancet Laboratories

More from World Health Organization Regional Office for the Western Pacific

More from Beijing VDJBio (China)

More from Digital China Health (China)